OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiangiogenic Therapy for Diabetic Nephropathy
Katsuyuki Tanabe, Yohei Maeshima, Yasufumi Sato, et al.
BioMed Research International (2017) Vol. 2017, pp. 1-12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Role of sirtuin-1 in diabetic nephropathy
Wanning Wang, Weixia Sun, Yanli Cheng, et al.
Journal of Molecular Medicine (2019) Vol. 97, Iss. 3, pp. 291-309
Open Access | Times Cited: 110

Targeting angiogenesis and lymphangiogenesis in kidney disease
Katsuyuki Tanabe, Jun Wada, Yasufumi Sato
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 289-303
Closed Access | Times Cited: 100

Natural antioxidants in diabetes treatment and management: prospects of astaxanthin
Osman N. Kanwugu, Т. В. Глухарева, Irina Danilova, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 18, pp. 5005-5028
Closed Access | Times Cited: 60

N6-methyladenosine RNA methylation in diabetic kidney disease
Jiaan Huang, Fan Yang, Yan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116185-116185
Open Access | Times Cited: 9

Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy
Afei Zhang, Huawei Fang, Jie Chen, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 70

Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats
Samar A. Antar, Walied Abdo, Reda S. Taha, et al.
Life Sciences (2021) Vol. 291, pp. 120260-120260
Closed Access | Times Cited: 48

The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium
Katharina Schlereth, Dieter Weichenhan, Tobias Bauer, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 56

The disruptive role of LRG1 on the vasculature and perivascular microenvironment
Athina Dritsoula, Carlotta Camilli, Stephen E. Moss, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 5

Exploring the NRF2/HO-1 and NF-κB Pathways: Spirulina Nanoparticles as a Novel Approach to Combat Diabetic Nephropathy
Fayez Althobaiti, Ehab S. Taher, Lamya Ahmed Al‐Keridis, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23949-23962
Open Access | Times Cited: 5

Glymphatic System: Emerging Therapeutic Target for Neurological Diseases
Xianjun Xuan, Guoyi Zhou, Caihong Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 21

The unique structural and functional characteristics of glomerular endothelial cell fenestrations and their potential as a therapeutic target in kidney disease
Natalie Finch, Chris Neal, Gavin I. Welsh, et al.
AJP Renal Physiology (2023) Vol. 325, Iss. 4, pp. F465-F478
Open Access | Times Cited: 12

Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives
Rajesh N. Gacche
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189020-189020
Closed Access | Times Cited: 11

Association between macular vessel density and microvascular biomarkers in pediatric chronic kidney disease
E. Mohamed, Samira Sayed, Lamia H. Ali, et al.
Journal of the Egyptian Ophthalmological Society (2025) Vol. 118, Iss. 1, pp. 43-54
Open Access

MiR‐92b‐3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy
Liping Wang, Jianan Geng, Bo Sun, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 28

The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Yayi Jiang, Jiacheng Shui, Boxun Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 28

Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs
Safaa H. Hammoud, Ibrahim AlZaim, Nahed Mougharbil, et al.
Biochemical Pharmacology (2021) Vol. 186, pp. 114491-114491
Open Access | Times Cited: 27

Kaempferol protects retinal ganglion ceils from high-glucose-induced injury by regulating vasohibin-1
Lu Zhao, Junbo Sun, Suqin Shi, et al.
Neuroscience Letters (2019) Vol. 716, pp. 134633-134633
Closed Access | Times Cited: 28

Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
Katsuyuki Tanabe, Yasufumi Sato, Jun Wada
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1859-1859
Open Access | Times Cited: 27

Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice
Sona Haku, Hiromichi Wakui, Kengo Azushima, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 26

Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis
Michael Rauchman, David W. Griggs
Translational research (2019) Vol. 209, pp. 90-104
Open Access | Times Cited: 23

Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
Florence Njau, Nelli Shushakova, Heiko Schenk, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0218494-e0218494
Open Access | Times Cited: 23

VASH-1 Regulates Oxidative Stress and Fibrosis in Diabetic Kidney Disease via SIRT1/HIF1α and TGFβ1/Smad3 Signaling Pathways
Huiwen Ren, Ying Shao, Can Wu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 20

Anti-Inflammatory and Immune Regulatory Actions of Naja naja atra Venom
Shuzhi Wang, Zheng‐Hong Qin
Toxins (2018) Vol. 10, Iss. 3, pp. 100-100
Open Access | Times Cited: 19

Transcription profiling of artemisinin-treated diabetic nephropathy rats using high-throughput sequencing
Min Xiang, Zhihong Chen, Liangping He, et al.
Life Sciences (2019) Vol. 219, pp. 353-363
Closed Access | Times Cited: 19

Page 1 - Next Page

Scroll to top